The Department of Defense Awards Terumo BCT Grant to Explore Feasibility of Next-Generation Mirasol

Hepatitis C, one of the many viruses deactivated from blood products using the Mirasol® Pathogen Reduction Technology System from Terumo BCT.LAKEWOOD, Colo., Dec. 6, 2017 /PRNewswire/ — The Department of Defense recently awarded Terumo BCT a three-year grant to explore the feasibility of further advancing blood safety by reducing pathogens in blood transfused to military personnel using the Mirasol® Pathogen Reduction…


GOT NEWS? click here

possible to reach millions worldwide
Google News, Bing News, Yahoo News, 200+ publications


About the author

forimmediaterelease.net -